List of Tables
    Table 1. Key Players of RNA-based Biopharmaceuticals in Global Market
    Table 2. Top RNA-based Biopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global RNA-based Biopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global RNA-based Biopharmaceuticals Revenue Share by Companies, 2017-2022
    Table 5. Global RNA-based Biopharmaceuticals Sales by Companies, (K Units), 2017-2022
    Table 6. Global RNA-based Biopharmaceuticals Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers RNA-based Biopharmaceuticals Price (2017-2022) & (USD/Unit)
    Table 8. Global Manufacturers RNA-based Biopharmaceuticals Product Type
    Table 9. List of Global Tier 1 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 RNA-based Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2017-2022
    Table 15. By Type - Global RNA-based Biopharmaceuticals Sales (K Units), 2023-2028
    Table 16. By Application – Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2017-2022
    Table 20. By Application - Global RNA-based Biopharmaceuticals Sales (K Units), 2023-2028
    Table 21. By Region – Global RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global RNA-based Biopharmaceuticals Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2017-2022
    Table 25. By Region - Global RNA-based Biopharmaceuticals Sales (K Units), 2023-2028
    Table 26. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2017-2022
    Table 29. By Country - North America RNA-based Biopharmaceuticals Sales, (K Units), 2023-2028
    Table 30. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2017-2022
    Table 33. By Country - Europe RNA-based Biopharmaceuticals Sales, (K Units), 2023-2028
    Table 34. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2017-2022
    Table 37. By Region - Asia RNA-based Biopharmaceuticals Sales, (K Units), 2023-2028
    Table 38. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2017-2022
    Table 41. By Country - South America RNA-based Biopharmaceuticals Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales, (K Units), 2023-2028
    Table 46. Pfizer Corporate Summary
    Table 47. Pfizer RNA-based Biopharmaceuticals Product Offerings
    Table 48. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 49. Roche Corporate Summary
    Table 50. Roche RNA-based Biopharmaceuticals Product Offerings
    Table 51. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 52. Sanofi-Aventis Corporate Summary
    Table 53. Sanofi-Aventis RNA-based Biopharmaceuticals Product Offerings
    Table 54. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 55. Abbott Laboratories Corporate Summary
    Table 56. Abbott Laboratories RNA-based Biopharmaceuticals Product Offerings
    Table 57. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 58. Arrowhead Pharmaceuticals Corporate Summary
    Table 59. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
    Table 60. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 61. Benitec Biopharma Corporate Summary
    Table 62. Benitec Biopharma RNA-based Biopharmaceuticals Product Offerings
    Table 63. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 64. Calimmune Inc Corporate Summary
    Table 65. Calimmune Inc RNA-based Biopharmaceuticals Product Offerings
    Table 66. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 67. Dicerna Corporate Summary
    Table 68. Dicerna RNA-based Biopharmaceuticals Product Offerings
    Table 69. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 70. Gradalis Corporate Summary
    Table 71. Gradalis RNA-based Biopharmaceuticals Product Offerings
    Table 72. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 73. Quark Corporate Summary
    Table 74. Quark RNA-based Biopharmaceuticals Product Offerings
    Table 75. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 76. RXi Corporate Summary
    Table 77. RXi RNA-based Biopharmaceuticals Product Offerings
    Table 78. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 79. Senesco Corporate Summary
    Table 80. Senesco RNA-based Biopharmaceuticals Product Offerings
    Table 81. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 82. Silence Therapeutics Corporate Summary
    Table 83. Silence Therapeutics RNA-based Biopharmaceuticals Product Offerings
    Table 84. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 85. Silenseed Corporate Summary
    Table 86. Silenseed RNA-based Biopharmaceuticals Product Offerings
    Table 87. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 88. Tekmira Corporate Summary
    Table 89. Tekmira RNA-based Biopharmaceuticals Product Offerings
    Table 90. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 91. Alnylam Pharmaceuticals Corporate Summary
    Table 92. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Offerings
    Table 93. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
    Table 94. RNA-based Biopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 95. Global RNA-based Biopharmaceuticals Capacity Market Share of Key Manufacturers, 2020-2022
    Table 96. Global RNA-based Biopharmaceuticals Production by Region, 2017-2022 (K Units)
    Table 97. Global RNA-based Biopharmaceuticals Production by Region, 2023-2028 (K Units)
    Table 98. RNA-based Biopharmaceuticals Market Opportunities & Trends in Global Market
    Table 99. RNA-based Biopharmaceuticals Market Drivers in Global Market
    Table 100. RNA-based Biopharmaceuticals Market Restraints in Global Market
    Table 101. RNA-based Biopharmaceuticals Raw Materials
    Table 102. RNA-based Biopharmaceuticals Raw Materials Suppliers in Global Market
    Table 103. Typical RNA-based Biopharmaceuticals Downstream
    Table 104. RNA-based Biopharmaceuticals Downstream Clients in Global Market
    Table 105. RNA-based Biopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. RNA-based Biopharmaceuticals Segment by Type
    Figure 2. RNA-based Biopharmaceuticals Segment by Application
    Figure 3. Global RNA-based Biopharmaceuticals Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global RNA-based Biopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global RNA-based Biopharmaceuticals Revenue, 2017-2028 (US$, Mn)
    Figure 7. RNA-based Biopharmaceuticals Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by RNA-based Biopharmaceuticals Revenue in 2021
    Figure 9. By Type - Global RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 10. By Type - Global RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 11. By Type - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2017-2028
    Figure 12. By Application - Global RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 13. By Application - Global RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 14. By Application - Global RNA-based Biopharmaceuticals Price (USD/Unit), 2017-2028
    Figure 15. By Region - Global RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 16. By Region - Global RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 17. By Country - North America RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 18. By Country - North America RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 19. US RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 24. Germany RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 25. France RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 33. China RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 37. India RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 39. By Country - South America RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 40. Brazil RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share, 2017-2028
    Figure 44. Turkey RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE RNA-based Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 48. Global RNA-based Biopharmaceuticals Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production RNA-based Biopharmaceuticals by Region, 2021 VS 2028
    Figure 50. RNA-based Biopharmaceuticals Industry Value Chain
    Figure 51. Marketing Channels